TherapeuticsMD (TXMD) Prices 26M Share Common Offering at $2.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Pre-Open 10/24: (TSLA) (AYR) (PYPL) Higher (ACOR) (TWTR) (TXMD) Lower (more...)
October 24, 2019 9:20 AM EDTToday's Pre-Open Movers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) 18.7% LOWER; JPMorgan downgraded from Neutral to Underweight.
Tesla (NASDAQ: TSLA) 18.2% HIGHER; reported Q3 EPS of $1.86, $2.28 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.33 billion.
Twitter (NYSE: TWTR) 17.1% LOWER; reported Q3 EPS of $0.17, $0.03 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $824 million versus the consensus estimate... More
After-Hours Movers 10/23: (TSLA) (MKSI) (PYPL) Higher; (TXMD) (NTGR) (EBAY) Lower (more...)
October 23, 2019 5:50 PM EDTToday's After-Hours Movers
Tesla (NASDAQ: TSLA) 18.2% HIGHER; reported Q3 EPS of $1.86, $2.28 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.33 billion.
TherapeuticsMD, Inc. (NASDAQ: TXMD) 16% LOWER; announced the launch of an underwritten public offering of 22,000,000 shares of its common stock. TherapeuticsMD also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 3,300,000 shares of common... More
TherapeuticsMD (TXMD) Announces Proposed Underwritten Public Offering of 22 Million Shares of Common
October 23, 2019 5:05 PM EDTTherapeuticsMD, Inc. (NASDAQ: TXMD) today announced the launch of an underwritten public offering of 22,000,000 shares of its common stock. TherapeuticsMD also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 3,300,000 shares of common stock at the public offering price, less the underwriting discount.... More

